These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii. Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177 [TBL] [Abstract][Full Text] [Related]
4. Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology. Russo TA; Beanan JM; Olson R; MacDonald U; Luke NR; Gill SR; Campagnari AA Infect Immun; 2008 Aug; 76(8):3577-86. PubMed ID: 18541654 [TBL] [Abstract][Full Text] [Related]
5. Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat. Lima WG; Alves MC; Cruz WS; Paiva MC Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1009-1019. PubMed ID: 29524060 [TBL] [Abstract][Full Text] [Related]
6. Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness. Johnson TL; Waack U; Smith S; Mobley H; Sandkvist M J Bacteriol; 2015 Dec; 198(4):711-9. PubMed ID: 26668261 [TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii. García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380 [TBL] [Abstract][Full Text] [Related]